EDSS
Expanded Disability Status Scale (EDSS) is a method of quantifying disability in Multiple Sclerosis (MS) and monitoring changes in the level of disability over time. It is part of the Multiple Sclerosis Functional Composite (MSFC) measure, which is widely used in clinical trials and in the assessment of individuals with MS. The EDSS scale ranges from 0 to 10 in 0.5 unit increments, representing increasing levels of disability. Scores of 0 to 4.5 refer to individuals who are fully ambulatory, while scores of 5.0 and above denote impairment to ambulation.
Overview[edit | edit source]
The EDSS was developed by John F. Kurtzke in the 1980s as a tool to assess the severity and progression of disability in MS patients. It focuses primarily on ambulation and the ability to carry out activities of daily living independently. The scale assesses eight functional systems (FS):
Each of these functional systems is scored separately, and then the scores are used to determine the overall EDSS score.
Scoring[edit | edit source]
The EDSS score is determined by both the functional system scores and an assessment of walking ability. The lower scores (0-4.5) are based primarily on the functional system scores, while the higher scores (5.0-9.5) are determined by the individual's ability to walk. For example, a score of 6.0 indicates that a person needs intermittent or unilateral assistance (such as a cane) to walk about 100 meters with or without resting.
Usage[edit | edit source]
The EDSS is used by neurologists and MS specialists to:
- Assess the progression of disability in individuals with MS
- Evaluate the effectiveness of treatments
- Serve as a standardized measure in clinical trials
Despite its widespread use, the EDSS has been criticized for its emphasis on ambulation and its lack of sensitivity to changes in non-ambulatory functions. Additionally, the subjective nature of the assessment can lead to variability in scoring.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD